May 19
|
3 Overrated Stocks Facing Headwinds
|
May 16
|
IRTC Q1 Earnings Call: Outperformance Driven by Zio AT and Primary Care Channel Expansion
|
May 15
|
2 Healthcare Stocks to Keep an Eye On and 1 to Ignore
|
May 15
|
Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest
|
Mar 11
|
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
|
Feb 22
|
iRhythm Technologies Full Year 2024 Earnings: Beats Expectations
|
Feb 21
|
iRhythm Technologies Inc (IRTC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
Feb 21
|
VitalConnect raises $100M for heart monitor patch
|
Feb 20
|
iRhythm (NASDAQ:IRTC) Reports Strong Q4, Stock Soars
|
Feb 20
|
IRhythm Technologies (IRTC) Beats Q4 Earnings and Revenue Estimates
|
Feb 20
|
iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results
|
Feb 19
|
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect
|
Feb 13
|
Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know
|
Feb 11
|
A Look At The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)
|
Jan 1
|
3 Undervalued US Stocks Estimated To Be Up To 30.8% Below Intrinsic Value
|
Dec 30
|
iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
Oct 11
|
Irhythm Technologies Outlines Growth and Market Leadership Strategy
|
Sep 4
|
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
|
Sep 4
|
iRhythm’s Wearable Monitor Found Heart Arrhythmias. It Didn’t Stop Strokes.
|
Sep 1
|
iRhythm Technologies Announces Results of GUARD-AF Trial
|